Research Article
Mortality among Cancer Patients within 90 Days of Therapy in a Tertiary Hospital, Tanzania: Is Our Pretherapy Screening Effective?
Table 1
Description of type of cancer seen during the study period.
| Variable | Frequency () | Percent (%) |
| Gynecological cancers | 47 | 46 | Cancer of the cervix | 40 | 39 | Uterine cancer | 5 | 4.9 | Ovarian cancer | 1 | 1 | Choriocarcinoma | 1 | 1 | Head and neck cancers | 12 | 12 | Squamous cell carcinoma of the head and neck | 5 | 4.9 | Adenocarcinoma of the head and neck | 3 | 2.9 | Retinoblastoma | 2 | 2 | Nasopharyngeal cancer | 1 | 1 | Sinonasal cancer | 1 | 1 | Connective tissue cancers (sarcoma) | 12 | 12 | Kaposi’s sarcoma | 6 | 6 | Malignant melanoma | 2 | 2 | Malignant phyllodes | 1 | 1 | Fibrosarcoma | 1 | 1 | Osteosarcoma | 1 | 1 | Chondrosarcoma | 1 | 1 | Breast cancer | 11 | 11 | Gastrointestinal cancers | 10 | 10 | Hepatocellular cancer | 4 | 4 | Pancreatic cancer | 2 | 2 | Colon cancer | 2 | 2 | Esophageal cancer | 1 | 1 | Biliary rhabdomyosarcoma | 1 | 1 | Hematolymphoid malignancies | 6 | 6 | Hodgkin lymphoma | 2 | 2 | Chronic myeloid leukemia | 1 | 1 | Acute myeloid leukemia | 1 | 1 | Burkitt’s lymphoma | 1 | 1 | Non-Hodgkin lymphoma | 1 | 1 | Genital and reproductive cancer | 2 | 2 | Perianal cancer | 1 | 1 | Prostate cancer | 1 | 1 | Lung cancer | 1 | 1 |
|
|